US56270V1061 - MGRX (XNAS)
Mangoceuticals, Inc. - Common Stock Share
2,40 USD
Current Prices from Mangoceuticals, Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
MGRX
|
USD
|
20.12.2024 23:48
|
2,40 USD
| 2,45 USD | -2,04 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -6,25 % | -9,43 % | -35,14 % | -52,94 % | -44,83 % | -96,00 % |
Company Profile for Mangoceuticals, Inc. - Common Stock Share
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Company Data for Mangoceuticals, Inc. - Common Stock Share
Name Mangoceuticals, Inc. - Common Stock
Company Mangoceuticals, Inc.
Symbol MGRX
Website https://www.mangorx.com
Primary Exchange
NASDAQ
ISIN US56270V1061
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Mr. Jacob D. Cohen
Country United States of America
Currency USD
Employees 0,0 T
Address 15110 North Dallas Parkway, 75248 Dallas
IPO Date 2023-03-21
Stock Splits
Date | Split |
---|---|
16.10.2024 | 1:15 |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | MGRX |
More Shares
Investors who Mangoceuticals, Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.